Early Diagnosis of Diabetes through the Eye

Photochemistry and Photobiology

Volumn 91, Issue 6, 2015, Pages 1497-1504

  Karumanchi, Devi Kalyan ^a   Gaillard, Elizabeth R ^a   Dillon, James ^a  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN;

CHEMISTRY; DIABETES MELLITUS; EYE; HUMAN; PATHOLOGY; SPECTROFLUOROMETRY; TIME FACTOR;

ALPHA-CRYSTALLINS; DIABETES MELLITUS; EYE; HUMANS; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 84946020117     PISSN: 00318655     EISSN: 17511097     Source Type: Journal    
DOI: 10.1111/php.12524     Document Type: Article

References (98)

1. Wilcox, G., (2005) Insulin and insulin resistance. Clin. Biochem. Rev. 26, 19.
2. Xu, J., and, M.-H. Zou, (2009) Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120, 1266-1286.
3. de la Maza, M. P., F. Garrido, N. Escalante, L. Leiva, G. Barrera, S. Schnitzler, M. Zanolli, J. Verdaguer, S. Hirsch, and, N. Jara, (2012) Fluorescent advanced glycation end-products (ages) detected by spectro-photofluorimetry, as a screening tool to detect diabetic microvascular complications. J. Diabetes Mellitus 2, 221.
4. Dall, T. M., W. Yang, P. Halder, B. Pang, M. Massoudi, N. Wintfeld, A. P. Semilla, J. Franz, and, P. F. Hogan, (2014) The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 37, 3172-3179.
5. Sacks, D. B., D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and, M. Parrott, (2002) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin. Chem. 48, 436-472.
6. Sacks, D. B., (2003) Hemoglobin variants and hemoglobin A1c analysis: problem solved? Clin. Chem. 49, 1245-1247.
7. Cohen, R. M., S. Haggerty, and, W. H. Herman, (2010) HbA1c for the diagnosis of diabetes and prediabetes: is it time for a mid-course correction? J. Clin. Endocrinol. Metab. 95, 5203-5206.
8. Cohen, R. M., R. S. Franco, P. K. Khera, E. P. Smith, C. J. Lindsell, P. J. Ciraolo, M. B. Palascak, and, C. H. Joiner, (2008) Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 112, 4284-4291.
9. Panzer, S., W. Graninger, G. Kronik, P. Bettelheim, and, K. Lechner, (1983) Glycosylated hemoglobin as a long-term parameter in appraising the severity of hemolytic disease. Klin. Wochenschr. 61, 839-843.
10. Dobler, D., N. Ahmed, L. Song, K. E. Eboigbodin, and, P. J. Thornalley, (2006) Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes 55, 1961-1969.
11. Shetty, P., R. Jung, K. Watrasiewicz, and, W. James, (1979) Rapid-turnover transport proteins: an index of subclinical protein-energy malnutrition. Lancet 314, 230-232.
12. Gillett, M. J., (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334. Clin. Biochem. Rev. 30, 197-200.
13. Reynolds, T. M., W. S. A. Smellie, and, P. J. Twomey, (2006) Cases in primary care laboratory medicine: Glycated haemoglobin (HbA1c) monitoring. BMJ 333, 586.
14. Tran, H. A., D. Silva, and, N. Petrovsky, (2004) Case study: potential pitfalls of using hemoglobin A1c as the sole measure of glycemic control. Clin. Diabetes 22, 141-143.
15. Bry, L., P. C. Chen, and, D. B. Sacks, (2001) Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin. Chem. 47, 153-163.
16. Little, R. R., C. L. Rohlfing, S. Hanson, S. Connolly, T. Higgins, C. W. Weykamp, M. D'Costa, V. Luzzi, W. E. Owen, and, W. L. Roberts, (2008) Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin. Chem. 54, 1277-1282.
17. Roberts, W. L., S. Safar-Pour, B. K. De, C. L. Rohlfing, C. W. Weykamp, and, R. R. Little, (2005) Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin. Chem. 51, 776-778.
18. Mongia, S. K., R. R. Little, C. L. Rohlfing, S. Hanson, R. F. Roberts, W. E. Owen, M. A. D'Costa, C. A. Reyes, V. I. Luzzi, and, W. L. Roberts, (2008) Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am. J. Clin. Pathol. 130, 136-140.
19. Association A. D. (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31, S55-S60.
20. Raman, B., T. Ramakrishna, and, C. Mohan Rao, (1995) Temperature dependent chaperone-like activity of alpha-crystallin. FEBS Lett. 365, 133-136.
21. Siezen, R. J., J. G. Bindels, and, H. J. Hoenders, (1980) The quaternary structure of bovine α-crystallin. Eur. J. Biochem. 111, 435-444.
22. Berger, J. W., and, J. M. Vanderkooi, (1990) The anaerobic photolysis of lens α-crystallin: evidence for triplet state mediated photodamage. Photochem. Photobiol. 52, 855-860.
23. De Jong, W., J. Leunissen, and, C. Voorter, (1993) Evolution of the alpha-crystallin/small heat-shock protein family. Mol. Biol. Evol. 10, 103-126.
24. Deng, M., P.-C. Chen, S. Xie, J. Zhao, L. Gong, J. Liu, L. Zhang, S. Sun, J. Liu, and, H. Ma, (2010) The small heat shock protein αA-crystallin is expressed in pancreas and acts as a negative regulator of carcinogenesis. Biochim. Biophys. Acta 1802, 621-631.
25. Fort, P. E., and, K. J. Lampi, (2011) New focus on alpha-crystallins in retinal neurodegenerative diseases. Exp. Eye Res. 92, 98-103.
26. Horwitz, J., (2003) Alpha-crystallin. Exp. Eye Res. 76, 145-153.
27. Horwitz, J., (1992) Alpha-crystallin can function as a molecular chaperone. Proc. Natl Acad. Sci. 89, 10449-10453.
28. Horwitz, J., (2000) The function of alpha-crystallin in vision. Proceedings of the Seminars in cell & developmental biology 11, 53-60.
29. Van Montfort, R., C. Slingsby, and, E. Vierling, (2002) Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv. Protein Chem. 59, 105-156.
30. Raman, B., and, C. M. Rao, (1994) Chaperone-like activity and quaternary structure of alpha-crystallin. J. Biol. Chem. 269, 27264-27268.
31. Spector, A., T. Freund, L.-K. Li, and, R. C. Augusteyn, (1971) Age-dependent changes in the structure of alpha crystallin. Invest. Ophthalmol. Vis. Sci. 10, 677-686.
32. Urbak, L., and, H. Vorum, (2011) Heat shock proteins in the human eye. Int. J. Proteomics 2010, 479571.
33. Ahmed, N., P. J. Thornalley, J. Dawczynski, S. Franke, J. Strobel, G. Stein, and, G. M. Haik, (2003) Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest. Ophthalmol. Vis. Sci. 44, 5287-5292.
34. Ahmed, N., (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67, 3-21.
35. Rabbani, N., and, P. J. Thornalley, (2012) Glycation research in amino acids: a place to call home. Amino Acids 42, 1087-1096.
36. Rabbani, N., and, P. J. Thornalley, (2012) Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome. Amino Acids 42, 1133-1142.
37. Thomas, M. C., (2011) Advanced glycation end products. Contrib. Nephrol. 170, 66-74.
38. Gangadhariah, M. H., B. Wang, M. Linetsky, C. Henning, R. Spanneberg, M. A. Glomb, and, R. H. Nagaraj, (2010) Hydroimidazolone modification of human αA-crystallin: effect on the chaperone function and protein refolding ability. Biochim. Biophys. Acta 1802, 432-441.
39. Monnier, V. M., D. R. Sell, Z. Dai, I. Nemet, F. Collard, and, J. Zhang, (2008) The role of the amadori product in the complications of diabetes. Ann. N. Y. Acad. Sci. 1126, 81-88.
40. Rosca, M. G., V. M. Monnier, L. I. Szweda, and, M. F. Weiss, (2002) Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal. Am. J. Physiol. Renal. Physiol. 283, F52-F59.
41. Rosca, M. G., T. G. Mustata, M. T. Kinter, A. M. Ozdemir, T. S. Kern, L. I. Szweda, M. Brownlee, V. M. Monnier, and, M. F. Weiss, (2005) Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am. J. Physiol. Renal. Physiol. 289, F420-F430.
42. Craig, E. A., J. S. Weissman, and, A. L. Horwich, (1994) Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell. Cell 78, 365-372.
43. Parsell, D. A., J. Taulien, and, S. Lindquist, (1993) The role of heat-shock proteins in thermotolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 339, 279-285; discussion 285-276.
44. Sterling, K., (1951) The turnover rate of serum albumin in man as measured by I131-tagged albumin. J. Clin. Investig. 30, 1228.
45. Mandal, K., J. Dillon, and, E. R. Gaillard, (2000) Heat and concentration effects on the small heat shock protein, alpha-crystallin. Photochem. Photobiol. 71, 470-475.
46. Mukhopadhyay, S., M. Kar, and, K. P. Das, (2010) Effect of methylglyoxal modification of human alpha-crystallin on the structure, stability and chaperone function. Protein. J. 29, 551-556.
47. Bursell, S.E., and, N.T. Yu, (1990) Fluorescence and Raman spectroscopy of the crystalline lens. In Noninvasive Diagnostic Techniques in Ophthalmology, (Edited by B. Masters), pp. 319-341. Springer-Verlag, New York.
48. Bartling, B., H. S. Hofmann, A. Sohst, Y. Hatzky, V. Somoza, R. E. Silber, and, A. Simm, (2011) Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma. Mol. Med. 17, 980-989.
49. Kessel, L., (2004) Lens fluorescence as a marker of ageing in relation to heritability, diabetes mellitus, and ischaemic heart disease. Dan. Med. Bull. 51, 298.
50. Vlassara, H., and, M. Palace, (2002) Diabetes and advanced glycation endproducts. J. Intern. Med. 251, 87-101.
51. Uribarri, J., W. Cai, M. Peppa, S. Goodman, L. Ferrucci, G. Striker, and, H. Vlassara, (2007) Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. J. Gerontol. A Biol. Sci. Med. Sci. 62, 427-433.
52. Stirban, A., M. Negrean, B. Stratmann, T. Gawlowski, T. Horstmann, C. Götting, K. Kleesiek, M. Mueller-Roesel, T. Koschinsky, and, J. Uribarri, (2006) Benfotiamine prevents macro-and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 29, 2064-2071.
53. Thornalley, P. J., (1996) Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27, 565-573.
54. Dakin, H., and, H. Dudley, (1913) An enzyme concerned with the formation of hydroxy acids from ketonic aldehydes. J. Biol. Chem. 14, 155-157.
55. McLellan, A. C., and, J. Thornalley, (1994) Glyoxalase system in clinical diabetes mellitus and correlation with diabetic com pl icat ions. Clin. Sci. 87, 21-29.
56. Kalapos, M. P., (1999) Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 110, 145-175.
57. Sparrow, J. M., A. J. Bron, N. A. Brown, and, H. A. Neil, (1992) Autofluorescence of the crystalline lens in early and late onset diabetes. Br. J. Ophthalmol. 76, 25-31.
58. Liang, J. N., (1990) Front surface fluorescence measurements of the age-related change in the human lens. Curr. Eye Res. 9, 399-405.
59. Bastiaens, P. I., and, A. Squire, (1999) Fluorescence lifetime imaging microscopy: spatial resolution of biochemical processes in the cell. Trends Cell Biol. 9, 48-52.
60. Lakowicz, J. R., (1992) Topics in Fluorescence Spectroscopy: Principles. Springer, New York.
61. Lakowicz, J. R., P. A. Koen, H. Szmacinski, I. Gryczynski, and, J. Kus̈ba, (1994) Emerging biomedical and advanced applications of time-resolved fluorescence spectroscopy. J. Fluoresc. 4, 117-136.
62. Beechem, J. M., and, L. Brand, (1985) Time-resolved fluorescence of proteins. Annu. Rev. Biochem. 54, 43-71.
63. Striker, G., V. Subramaniam, C. A. Seidel, and, A. Volkmer, (1999) Photochromicity and fluorescence lifetimes of green fluorescent protein. J. Phys. Chem. B 103, 8612-8617.
64. Kessel, L., S. Kalinin, R. H. Nagaraj, M. Larsen, and, L. B. Å. Johansson, (2002) Time-resolved and steady-state fluorescence spectroscopic studies of the human lens with comparison to argpyrimidine, pentosidine and 3-OH-kynurenine. Photochem. Photobiol. 76, 549-554.
65. Kessel, L., S. Kalinin, V. Soroka, M. Larsen, and, L. B. Johansson, (2005) Impact of UVR-A on whole human lenses, supernatants of buffered human lens homogenates, and purified argpyrimidine and 3-OH-kynurenine. Acta Ophthalmol. Scand. 83, 221-227.
66. Kessel, L., and, M. Larsen, and I. S. Group (2003) Lens fluorescence in newly diagnosed type 2 diabetic patients. Invest. Ophthalmol. Vis. Sci. 44, 3471.
67. Roberts, J. E., S. J. Atherton, E. R. Gaillard, and, J. Dillon, (1995) Age-related changes in the human lens as monitored by detection of porphyrin excited states. Photochem. Photobiol. 62, 339-341.
68. Borkman, R., J. Tassin, and, S. Lerman, (1980) Fluorescence lifetimes of ocular lens chromophores. Photochem. Photobiol. 31, 519-521.
69. Borkman, R. F., Cataracts and photochemical damage in the lens. pp. 88-109. Wiley Online Library, Proceedings of the Ciba Foundation Symposium 106-Human Cataract Formation1984.
70. Borkman, R. F., A. Douhal, and, K. Yoshihara, (1993) Picosecond fluorescence decay in photolyzed lens protein alpha-crystallin. Biochemistry 32, 4787-4792.
71. Borkman, R. F., and, S. Lerman, (1978) Fluorescence spectra of tryptophan residues in human and bovine lens proteins. Exp. Eye Res. 26, 705-713.
72. Kurzel, R., M. Wolbarsht, B. Yamanashi, G. Staton, and, R. Borkman, (1973) Tryptophan excited states and cataracts in the human lens.
73. Borkman, R. F., A. Dalrymple, and, S. Lerman, (1977) Ultraviolet action spectrum for fluorogen production in the ocular lens. Photochem. Photobiol. 26, 129-132.
74. Borkman, R. F., J. D. Tassin, and, S. Lerman, (1981) Fluorescence lifetimes of chromophores in intact human lenses and lens protection. Exp. Eye Res. 32, 313-322.
75. Lerman, S., and, R. Borkman, (1976) Spectroscopic evaluation and classification of the normal, aging, and cataractous lens. (with 1 color plate). Ophthalmic Res. 8, 335-353.
76. Lerman, S., and, R. Borkman, (1978) Photochemistry and lens aging. Interdiscip. Top. Gerontol. 13, 154-182.
77. Lerman, S., J. Jr Kuck, R. Borkman, and, E. Saker, (1976) Accleration of an aging parameter (fluorogen) in the ocular lens. Ann. Ophthalmol. 8, 558.
78. Lerman, S., B. Yamanashi, R. Palmer, J. Roark, and, R. Borkman, (1978) Photoacoustic, fluorescence and light transmission spectra of normal, aging and cataractous lenses. Ophthalmic Res. 10, 168-176.
79. Atherton, S. J., C. Lambert, J. Schultz, N. Williams, and, S. Zigman, (1999) Fluorescence studies of lens epithelial cells and their constituents. Photochem. Photobiol. 70, 823-828.
80. Dillon, J., and, S. J. Atherton, (1990) Time resolved spectroscopic studies on the intact human lens. Photochem. Photobiol. 51, 465-468.
81. Vigneshwaran, N., G. Bijukumar, N. Karmakar, S. Anand, and, A. Misra, (2005) Autofluorescence characterization of advanced glycation end products of hemoglobin. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 61, 163-170.
82. de La Rochette, A., I. Birlouez-Aragon, E. Silva, and, P. Morliere, (2003) Advanced glycation endproducts as UVA photosensitizers of tryptophan and ascorbic acid: consequences for the lens. Biochim. Biophys. Acta 1621, 235-241.
83. Fuentealba, D., M. Galvez, E. Alarcon, E. Lissi, and, E. Silva, (2007) Photosensitizing activity of advanced glycation endproducts on tryptophan, glucose 6-phosphate dehydrogenase, human serum albumin and ascorbic acid evaluated at low oxygen pressure. Photochem. Photobiol. 83, 563-569.
84. Argirova, M. D., and, W. Breipohl, (2002) Glycated proteins can enhance photooxidative stress in aged and diabetic lenses. Free Radical Res. 36, 1251-1259.
85. Ortwerth, B. J., J. Bhattacharyya, and, E. Shipova, (2009) Tryptophan metabolites from young human lenses and the photooxidation of ascorbic acid by UVA light. Invest. Ophthalmol. Vis. Sci. 50, 3311-3319.
86. Wondrak, G. T., M. K. Jacobson, and, E. L. Jacobson, (2006) Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem. Photobiol. Sci. 5, 215-237.
87. Masaki, H., Y. Okano, and, H. Sakurai, (1999) Generation of active oxygen species from advanced glycation end-products (AGEs) during ultraviolet light A (UVA) irradiation and a possible mechanism for cell damaging. Biochim. Biophys. Acta 1428, 45-56.
88. Ortwerth, B. J., M. Prabhakaram, R. H. Nagaraj, and, M. Linetsky, (1997) The relative UV sensitizer activity of purified advanced glycation endproducts. Photochem. Photobiol. 65, 666-672.
89. Sauer, M., J. Hofkens, and, J. Enderlein, (2011) Basic Principles of Fluorescence Spectroscopy. In Handbook of Fluorescence Spectroscopy and Imaging: From Single Molecules to Ensembles, pp. 1-30. Wiley-VCH, Weinheim.
90. Burstein, E., N. Vedenkina, and, M. Ivkova, (1973) Fluorescence and the location of tryptophan residues in protein molecules. Photochem. Photobiol. 18, 263-279.
91. Chen, Y., and, M. D. Barkley, (1998) Toward understanding tryptophan fluorescence in proteins. Biochemistry 37, 9976-9982.
92. Schweitzer, D., (2011) Time resolved autofluorescence-a new diagnostic tool in ophthalmology. Acta Ophthalmol. 89.
93. Hammer, M., S. Quick, M. Klemm, S. Schenke, N. Mata, A. Eitner, and, D. Schweitzer,. In vivo and in vitro investigations of retinal fluorophores in age-related macular degeneration by fluorescence lifetime imaging. pp. 71832S-71832S-71812. International Society for Optics and Photonics, Proceedings of the SPIE BiOS: Biomedical Optics2009.
94. Schweitzer, D., E. Gaillard, M. Hammer, F. Schweitzer, R. Anders, T. Doebbecke, and, S. Schenke, (2004) In vivo measurement of time-resolved autofluorescence at the human fundus. J. Biomed. Optics 9, 1214-1222.
95. Schweitzer, D., E. R. Gaillard, J. Dillon, R. F. Mullins, S. Russell, B. Hoffmann, S. Peters, M. Hammer, and, C. Biskup, (2012) Time-resolved autofluorescence imaging of human donor retina tissue from donors with significant extramacular drusen. Invest. Ophthalmol. Vis. Sci. 53, 3376-3386.
96. Schweitzer, D., M. Hammer, and, F. Schweitzer, (2005) Limits of the confocal laser-scanning technique in measurements of time-resolved autofluorescence of the ocular fundus. Biomed. Tech. 50, 263-267.
97. Schweitzer, D., S. Quick, M. Klemm, M. Hammer, S. Jentsch, and, J. Dawczynski, (2010) Time-resolved autofluorescence in retinal vascular occlusions. Ophthalmologe 107, 1145-1152.
98. Velez, G., and, J. J. Weiter, (2002) Cataract extraction and age-related macular degeneration: associations, diagnosis and management. Semin. Ophthalmol. 17, 187-195.